Want to see HK:2211 full AI Analyst Report?
Universal Health International Group Holding Ltd. (2211) AI Stock Analysis
Universal Health International Group Holding Ltd.
(HKEX:2211)
The score is primarily held down by weak financial performance—shrinking revenue, recurring losses, and persistent negative operating/free cash flow—despite low leverage. Technicals offer only partial support (above shorter-term moving averages but still below the 200-day), while valuation is constrained by a negative P/E and no dividend data.
Universal Health International Group Holding Ltd. (2211) vs. iShares MSCI Hong Kong ETF (EWH)
- Market Cap
- HKD 39.96M
- Dividend Yield
- ―
- Average Volume (3M)
- 5.40M
- Price to Earnings (P/E)
- -2.2
- Beta (1Y)
- 1.41
- Revenue Growth
- -24.60%
- EPS Growth
- 36.73%
- Country
- Hong Kong
- Employees
- 601
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Pharmaceuticals
Universal Health International Group Holding Ltd. Business Overview & Revenue Model
Company Description
Operating as an investment holding company, Universal Health International Group Holding Limited specializes in the wholesale, retail, and distribution of a comprehensive range of pharmaceutical and healthcare products across China's northeastern reg...
How the Company Makes Money
null
Universal Health International Group Holding Ltd. Financial Statement Overview
Summary
Financial performance is weak: revenue has been shrinking (down ~24% in FY2025 after declines in FY2024), profitability is inconsistent with FY2025 returning to operating and net losses, and cash generation is persistently negative (operating cash flow and free cash flow negative across all years shown). The key offset is a comparatively conservative balance sheet with low leverage (debt-to-equity ~0.08 in FY2025), but overall the statements point to a need for sustained revenue stabilization and a path to cash-flow breakeven.
Income Statement
34NegativeBalance Sheet
62PositiveCash Flow
22Negative| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 519.49M | 520.69M | 711.51M | 1.09B | 1.30B | 1.27B |
| Gross Profit | 81.13M | 74.57M | 106.49M | 179.88M | 222.60M | 215.32M |
| EBITDA | 6.17M | 6.17M | -11.63M | 12.59M | -70.16M | -160.78M |
| Net Income | -20.44M | -20.49M | -26.01M | 413.00K | -105.40M | -187.65M |
Balance Sheet | ||||||
| Total Assets | 444.06M | 444.06M | 447.60M | 692.88M | 797.10M | 983.55M |
| Cash, Cash Equivalents and Short-Term Investments | 58.87M | 58.87M | 13.40M | 36.92M | 89.37M | 58.63M |
| Total Debt | 47.14M | 47.14M | 25.00M | 70.60M | 40.62M | 40.00M |
| Total Liabilities | 102.73M | 102.73M | 130.03M | 339.99M | 457.57M | 504.47M |
| Stockholders Equity | 341.33M | 341.33M | 317.57M | 352.72M | 314.73M | 408.13M |
Cash Flow | ||||||
| Free Cash Flow | 20.74M | 0 | -59.91M | -101.75M | -19.47M | -47.94M |
| Operating Cash Flow | 20.76M | 0 | -59.84M | -101.73M | -19.40M | -47.81M |
| Investing Cash Flow | 6.26M | 0 | 52.61M | 54.88M | -8.02M | 11.09M |
| Financing Cash Flow | 21.86M | 0 | -6.05M | 40.23M | 11.27M | 55.96M |
Universal Health International Group Holding Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2211, the sentiment is Positive. The current price of 0.45 is above the 20-day moving average (MA) of 0.43, below the 50-day MA of 0.47, and below the 200-day MA of 0.58, indicating a neutral trend. The MACD of -0.01 indicates Negative momentum. The RSI at 52.79 is Neutral, neither overbought nor oversold. The STOCH value of 87.88 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:2211.
Universal Health International Group Holding Ltd. Peers Comparison
Overall Rating
HK:215956Neutral
HK:386954Neutral
HK:072242Neutral
HK:213842Neutral- HK:221142Neutral
HK:388641Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| HK:2159 | 56Neutral | HKD 528.27M | 9.63 | 28.00% | ― | 91.32% | ― |
| HK:3869 | 54Neutral | HKD 467.79M | -143.62 | -0.41% | ― | 3.16% | -101.02% |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| HK:0722 | 42Neutral | HKD 292.35M | -3.79 | -10.76% | 9.04% | -1.37% | -334.69% |
| HK:2138 | 42Neutral | HKD 645.94M | -1.61 | -25.36% | ― | -8.94% | -140.82% |
| HK:2211 | 42Neutral | HKD 248.73M | -2.22 | -5.98% | ― | -24.60% | 36.73% |
| HK:3886 | 41Neutral | HKD 1.10B | 78.09 | 0.48% | 1.10% | -3.26% | ― |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| HK:2211 | Universal Health International Group Holding Ltd. | 0.45 | -0.90 | -66.57% | |
| HK:2138 | EC Healthcare | 0.55 | -0.10 | -16.15% | |
| HK:2159 | Mediwelcome Healthcare Management & Technology Inc. | 1.57 | 0.40 | 34.19% | |
| HK:3869 | Hospital Corporation of China Ltd | 3.38 | -2.61 | -43.49% | |
| HK:3886 | Town Health International Medical Group Ltd. | 0.16 | -0.11 | -40.07% | |
| HK:0722 | UMP Healthcare Holdings Limited | 0.36 | -0.07 | -16.67% |
Universal Health International Group Holding Ltd. Corporate Events
Universal Health Revises Timetable for Capital Reorganisation and Rights Issue
Universal Health International Group Holding Ltd., a Cayman Islands-incorporated healthcare company listed on the Hong Kong Stock Exchange under stock code 2211, is pursuing a capital reorganisation and rights issue to reshape its equity base. The mo...
Universal Health Plans Capital Reorganisation and Major Rights Issue
Universal Health International Group Holding Ltd., a Cayman Islands‑incorporated healthcare company listed in Hong Kong, is reshaping its share capital to strengthen its balance sheet. The firm’s shares, traded under stock code 2211, prov...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Jul 31, 2026